We use cookies to enhance site navigation, analyze site usage, and for our marketing efforts. By accepting, you consent to our Privacy Policy You may change your settings at any time by clicking "Cookie Consent" at the bottom of every page.


These technologies are required to activate the essential functions of our range of services.


These cookies collect information about the use of the website so that its content and functionality can be improved in order to increase the attractiveness of the website. These cookies may be set by third party providers whose services our website uses. These cookies are only set and used with your express prior consent.


These cookies are set by our advertising partners on our website and can be used to create a profile of your interests and show you relevant advertising on other websites (across websites).

The New Health Club x Fotografiska

A Talk Series on Psychedelics & New Consciousness (Live-Podcast)

An abstract blue painting with a hint of red and yellow.

We live in times where the idea around drugs and psychedelics is evolving. We're witnessing a 'global psychedelic renaissance', in Anne Philippi's words.

These substances are being rediscovered as tools to enhance our creativity, self discovery and connection to others. Research is happening around the topic of drugs used to fight depression but also their potential in enhancing our consciousness as humans.

To shine more of light on this fascinating yet controversial topic, Anne Philippi, founder of the advocacy group The New Health Club, is hosting a live podcast session in the Fotografiska Ballroom.

Additional speakers on this day will be Finn A. Hänsel, Sergio Pérez Rosal, Sarah Tilley und Tommaso Barba.


Anne Philippi

Born in Alsace, based in Berlin, Anne Philippi is a former author & reporter at Vanity Fair, GQ & VOGUE. She worked as a Silicon Valley correspondent for Frankfurter Allgemeine Zeitung and Frankfurter Allgemeine Quarterly. She lived in Los Angeles for six years as a Hollywood reporter for GQ Germany, wrote about the west coast tech world and Silicon Valley.

She discovered psychedelic assisted therapy in 2019 and founded The New Health Club Show podcast and newsletter, created a space where people from the new psychedelic ecosystem and business could talk abut the disruptive power of psychedelics. By 2021 she was part of the 100 most import people in psychedelics and is part of the international, psychedelic ecosystem and industry.

Now The New Health Club is working on introducing psychedelic tools back into society & culture, and creating new narratives, podcasts and products around the new health we need in our world.

Finn A. Hänsel

Finn A. Hänsel is Managing Director and one of the founders of Sanity Group. As former Managing Director of the European moving platform Movinga and former management consultant at BCG, he has many years of experience in building successful companies. In Australia, as MD of Rocket Internet Australia, he built up the fashion platform The Iconic, and subsequently served as Managing Director of the ProSieben Sat.1 incubator Epic Companies. In 2015, Finn Hänsel co-founded the craft beer brewery Berliner Berg. He is a board member of the Federal Association of German Startups (Bundesverband Deutsche Startups) and acts as a mentor for the start-up accelerator Techstars. Finn Hänsel was awarded "Founder of the Year" at the German Startup Awards 2021.

Sergio Pérez Rosal

Sergio Pérez Rosal, MD, stands at the forefront of pioneering efforts in the integration of traditional medical practices with innovative psychedelic and cannabis-based treatments. With a robust foundation in anesthesia, intensive care, and emergency medicine, he has notably contributed to the establishment of the first clinic in Germany dedicated to psychedelic medicine, assuming leadership roles that have shaped the trajectory of the field.

His expertise extends beyond clinical practice into the realms of education and advocacy, where he has been instrumental in organizing and leading public discourse on the potential of psychedelic substances in mental health treatment and human development. Recognizing the necessity for a standardized, secular, and inclusive approach to this emerging science, Sergio has developed comprehensive educational programs aimed at equipping professionals with the knowledge and skills required for effective, evidence-based application of psychedelic-augmented psychotherapy and integration therapy.

In addition to his medical and scientific endeavors, Sergio is currently enriching his understanding of the human mind through cognitive-behavioral psychotherapy training and a master’s degree in Neuroscience and Psychology. His dedication to advancing the field is evident in his hands-on workshops on Integration, drug-related emergency training, and mindfulness interventions in psychotherapy, which underscore his commitment to both professional development and patient care.

Sergio Pérez Rosal's vision extends beyond the pharmacological impact of psychedelics, advocating for a comprehensive approach that encompasses the broader implications for mental health treatment and societal well-being. His work signifies a crucial step towards the realization of psychedelic substances as valuable tools in the quest for psychological and developmental breakthroughs.

Sarah Tilley

Sarah Tilley, founder of Beautiful Space, specialises in psychedelic-assisted therapy helping couples reset intimacy and craft a new, sacred part of their story. Sarah's approach blends music, traditional plant medicine, altered consciousness and sexual wellness. With over 20 years of experience and 6 years of training under Esther Perel, Sarah is an exceptional guide for those seeking profound and meaningful change in life and their relationships.

Tommaso Barba

Tommaso Barba is a PhD candidate at the Centre for Psychedelic Research, Imperial College London, under the supervision of Dr David Erritzoe and Prof David Nutt. Tommaso's research is focused on understanding the brain effects of short-acting psychedelics, like DMT and 5-MeO-DMT, and the potential role of psychedelic drugs for depression and wellbeing. Tommaso is the leading author on the first scientific paper investing the effects of psychedelics on sexual functioning, recently published in Nature Scientific Reports. Tommaso is particularly interested in the effects of psychedelics and MDMA on romantic love and couples’ intimacy, believing that these drugs hold potential for improving couples' connection when administered in the right settings, like couples therapy. He has a background in neuroscience and psychoanalysis and graduated cum laude from Maastricht University.